急性缺血性卒中中的免疫血栓形成
本文综述缺血性卒中中免疫血栓形成与血栓炎症的概念,探讨免疫细胞通过促进血小板募集和凝血酶激活参与血栓形成,影响血管再通和患者结局,并阐述免疫细胞活化参与血栓形成的可能机制。
要点
- 循环免疫细胞可诱导免疫血栓形成,通过促进血小板募集和凝血酶激活参与血栓形成。
- 血栓炎症形成导致动脉粥样硬化斑块不稳定性增加。
- 免疫细胞影响血管再通和患者结局,其活化参与血栓形成的机制尚待阐明。
核心结论
- 免疫细胞与卒中发病机制密不可分,循环免疫细胞可诱导免疫血栓形成并参与血栓形成,血栓炎症增加斑块不稳定性,免疫细胞影响血管再通和患者结局。
研究设计与样本
- 综述,总结卒中免疫血栓形成和血栓炎症的概念以及免疫细胞对血管再通和患者结局的影响。
主要发现
- 循环免疫细胞通过促进血小板募集和凝血酶激活主动参与血栓形成。
- 血栓炎症形成导致动脉粥样硬化斑块不稳定性增加。
- 免疫细胞影响血管再通和患者结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischemic stroke is one of the leading causes of disability and mortality worldwide. Thrombosis is the main pathological process of stroke and is therefore an important therapeutic target in stroke prevention. In recent years, with the development of endovascular treatment and therefore retrieving the thrombus for further investigation, evidence is accumulating that immune cells are inextricably linked to stroke pathogenesis. Circulating immune cells have been found to induce immunothrombosis, and they actively participate in the formation of the thrombus by promoting platelet recruitment and thrombin activation. Additionally, the formation of thromboinflammation leads to increased instability of atherosclerotic plaques. We review the concepts of stroke immunothrombosis and thromboinflammation and the effect of immune cells on vessel recanalization and patient outcome. In addition, we elaborate on the possible mechanism of immune cells being activated and participating in thrombosis in ischemic stroke.
引用
- Wang Y, Mulder IA, Westendorp WF, et al. Immunothrombosis in Acute Ischemic Stroke. Stroke. 2024. PMID: 39479751. doi:10.1161/STROKEAHA.124.048137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。